Indication

PTEN Gene Deletion

1 clinical trial

1 product

Clinical trial

A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Status: Recruiting, Estimated PCD: 2024-08-30

Product